Delivery Order SPE2DR25D3306-SPE2DR26F5F2C
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $50K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,882.12 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price, non-set-aside contract was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling through December 2026....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,991.52 to AmerisourceBergen Drug Corp for Deferasirox 500 mg tablets for suspension (30-count units) on September 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by September 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $32,834.44 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units) with a completion date of December 4, 2025. The award, issued on December 3, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this delivery order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 360 mg Deferasirox tablets (30-count units) on May 16, 2025, with a ceiling value of $5,673.37 and an ultimate completion date of May 19, 2025. This is a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award represents a competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract valued at $22,697.07, with an ultimate completion date of December 11, 2025. This non-set-aside delivery order represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting the agency's ongoing procurement of specialized pharmaceuticals to support military and federal...
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency awarded a $10,368 delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg granule packets (30 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award was competitively awarded without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $43,387.99. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg tablets (30-count) with a ceiling value of $48,938.95. This firm fixed-price delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Deferasirox 500 mg tablets for suspension in a 30-count package, with a ceiling value of $3,356.72. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of November 25, 2025, and was issued on November 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...